Anti-beta Amyloid 1-42 抗体 [mOC64]
Anti-beta Amyloid 1-42 antibody [mOC64]
- 20ul selling size
- RabMAb
- Recombinant
- 詳細を見る
5
(8 Reviews)
|
(140 Publications)
Anti-beta Amyloid 1-42 antibody [mOC64] (ab201060) is a rabbit monoclonal antibody detecting beta Amyloid 1-42 in IHC-P, IHC-Fr, Dot Blot. Suitable for Human, Mouse, Rat.
- Over 80 publications
別名を表示する
A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-beta Amyloid 1-42 antibody [mOC64] (AB201060)
Immunohistochemical analysis of formalin fixed paraffin embedded human alzheimer brain labelling beta Amyloid with ab201060 at a concentration of 0.1μg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
ab201060 Anti-beta Amyloid 1-42 antibody [mOC64] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-beta Amyloid 1-42 antibody [mOC64] (AB201060)
Composite multiplex immunofluorescence staining of APP, PSD95 and Tau staining in a section of formalin-fixed paraffin-embedded human Alzheimer’s brain*.
Performed on a Leica BOND. The section was pre-treated using heat mediated antigen retrieval with EDTA (Ph9.0) using retrieval settings of 100°C for 40 minutes. The section was then incubated at room temperature for 1 hour with ab201060 at 1µg/ml dilution (shown in green), ab317793 at 1µg/ml (shown in magenta), and ab317841 at 1µg/ml (shown in yellow). Then incubated for 1 hour with ab150118 Goat Anti-Mouse IgG H&L (Alexa Fluor® 555) preadsorbed 1/1000, ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed 1/1000, and ab150135 Donkey Anti-Goat IgG H&L (Alexa Fluor® 647) preadsorbed 1/1000. Nuclear DNA was labelled with DAPI (shown in blue). The section was then mounted using Dako Fluorescence Mounting Medium ®.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre.
- Dot
Supplier Data
Dot Blot - Anti-beta Amyloid 1-42 antibody [mOC64] (AB201060)
Dot blot analysis of human beta Amyloid 1-42 labeled with ab201060 at 1/7000 dilution.
Lane 1 : beta Amyloid (Aβ) 1-40.
Lane 2 : beta Amyloid (Aβ) 1-42.
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/5000 dilution was used as secondary antibody.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.
Antibody reactivity was assessed using a dot blot, which is a non-quantitative method that maintains the native conformation of beta Amyloid. Beta Amyloid 1-40 and 1-42 peptides underwent the following aggregation conditions before being spotted onto a nitrocellulose membrane and detected using ab201060 :
Monomers : 0.3 mg of beta Amyloid peptide was dissolved in 30 μl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 μl of 1% SDS and boiled for five minutes.
Oligomers : 0.3 mg of beta Amyloid peptide was dissolved in 30 μl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 μl of 10 mM phosphate buffer pH 7.4 containing 0.02% sodium azide and incubated at room temperature for four days.
Fibrils : 0.3 mg of beta Amyloid peptide was dissolved in 1 ml 50% hexafluoroisopropanol (HFIP) with 0.02% sodium azide. It was then stirred constantly for nine days; the first seven with a cap on and the final two with the cap removed to allow evaporation of the HFIP. Fibrils were then sedimented at 20,000 rpm in a microcentrifuge for 20 minutes and resuspended in 1 ml of PBS + 0.02% sodium azide.
- Dot
Supplier Data
Dot Blot - Anti-beta Amyloid 1-42 antibody [mOC64] (AB201060)
Negative control (secondary ab only) :
Lane 1 : Human beta Amyloid (Aβ) 1-40.
Lane 2 : Human beta Amyloid (Aβ) 1-42.
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/5000 dilution was used as secondary antibody.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.
関連する標識済み抗体及び組成の異なる製品 (7)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-beta Amyloid 1-42 antibody [mOC64]
-
Anti-beta Amyloid 1-42 antibody [mOC64] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-beta Amyloid 1-42 antibody [mOC64]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-beta Amyloid 1-42 antibody [mOC64]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-beta Amyloid 1-42 antibody [mOC64]
-
Anti-beta Amyloid 1-42 antibody [mOC64] - Low endotoxin, Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-beta Amyloid 1-42 antibody [mOC64]
Reactivity data
製品の詳細
Anti-beta Amyloid 1-42 antibody [mOC64] (ab201060) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Dot blot, IHC-FrFl, IHC-P in human, mouse, rat samples.
Anti-beta Amyloid 1-42 antibody [mOC64] (ab201060) has been cited over 82 times in peer reviewed journals and is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-beta Amyloid 1-42 antibody [mOC64] (ab201060) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-beta Amyloid 1-42 antibody [mOC64] (ab201060) has 8 independent reviews from customers.
Anti-beta Amyloid 1-42 antibody [mOC64] (ab201060) specifically detects beta Amyloid 1-42 (UniProt ID: P05067; Molecular weight: 85kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Conjugation-ready, carrier free format available for antibody clone mOC64 - ab271968.
Antibody clone mOC64 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Alexa Fluor® 488, Alexa Fluor® 647, Alexa Fluor® 555, Alexa Fluor® 568 (ab224025, ab224026, ab300742, ab302544, ab302803).
This antibody was developed as part of a collaboration between Abcam and Professor Charles Glabe, UC Irvine.
mOC64 immunoreactivity maps to residues 3-6 (EFRH) of Aß. It does not recognize pyproglytaminylated Aß at position 3 (Aß3(pE)–42) (Nussbaum et al. 2012, PMID: 22660329 and Hatami et al. 2014, PMID: 25281743).
For further information on the immunogen, please refer to Hatami et al. 2014, 25281743 and Kayed et al. 2007, PMID: 17897471.
Browse our curated portfolio of extensively validated recombinant antibodies and assays sensitive to Tau, Beta-amyloid, and other Alzheimer’s targets of interest, with everything you need in one place.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Amyloid beta 1-42 plays a central role in synaptic activity and neuronal health. While not inherently pathogenic its tendency to aggregate forms oligomers and fibrils which become toxic to neurons. This peptide contributes to synaptic dysfunction and neuronal cell death and is a major component of extracellular amyloid plaques found in brain tissue. Within the cellular environment amyloid beta 1-42 can interact with receptors membrane lipids and intracellular signaling mechanisms thereby affecting neuronal cell function.
Pathways
Amyloid beta 1-42 is important in the amyloidogenic pathway which is one of the critical components in APP processing. The pathway includes proteolytic enzymes like beta secretase (BACE1) and gamma secretase where misregulation may lead to excessive production or deposition of amyloid beta peptides. Another related pathway is the tau protein phosphorylation pathway which indirectly interacts with amyloid beta 1-42 due to shared signaling intermediates impacting tau stabilization and microtubule assembly in neurons.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (140)
Recent publications for all applications. Explore the full list and refine your search
European journal of nuclear medicine and molecular imaging : PubMed40956407
2025
Applications
Unspecified application
Species
Unspecified reactive species
Neuropsychiatric disease and treatment 21:1911-1933 PubMed40926795
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1632640 PubMed40771917
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed40762561
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:112817 PubMed40599314
2025
Applications
Unspecified application
Species
Unspecified reactive species
Aging and disease : PubMed40586384
2025
Applications
Unspecified application
Species
Unspecified reactive species
Alzheimer's research & therapy 17:141 PubMed40551167
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 32:101841 PubMed40469696
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 17:1579411 PubMed40443793
2025
Applications
Unspecified application
Species
Unspecified reactive species
Neurophotonics 12:S14610 PubMed40405889
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com